Fig. 1From: Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directionsNovel therapies targeting different elements involved in PDAC development. Therapeutics targeting signaling pathways participating in tumorigenesis and progression, the tumor microenvironment, inflammatory and immune responses, and angiogenesis. It also contains future possible therapeutic targets and specific biomarkers for the evaluation of efficacyBack to article page